The BFRF1 gene of Epstein-Barr virus encodes a novel protein

Journal of Virology

Volumn 74, Issue 7, 2000, Pages 3235-3244

  Farina, Antonella ^d   Santarelli, Roberta ^d   Gonnella, Roberta ^d   Bei, Roberto ^d   Muraro, Raffaella ^a   Cardinali, Giorgia ^d   Uccini, Stefania ^d   Ragona, Giuseppe ^b   Frati, Luigi ^b   Faggioni, Alberto ^c   Angeloni, Antonio ^d  

^a UNIVERSITY OF CHIETI   (Italy)

^b IRCCS NEUROMED   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; DNA POLYMERASE; GLUTATHIONE TRANSFERASE; HISTIDINE; HYBRID PROTEIN; MONOCLONAL ANTIBODY; PHOSPHONOACETIC ACID; PROTEIN BFRF1; RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; BURKITT LYMPHOMA; CELL FRACTIONATION; CELL MEMBRANE; CELL NUCLEUS; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; NASOPHARYNX CARCINOMA; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEROPREVALENCE; VIRUS INFECTION; VIRUS PARTICLE; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; GENES, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; RECOMBINANT PROTEINS; RNA, MESSENGER; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 17344388440     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.7.3235-3244.2000     Document Type: Article

References (41)

1. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, P. S. Tuffnell, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (London) 310:207-211.
2. Bei, R., A. Moretti, V. Visco, R. De Filippi, K. Y. Tsang, L. Frati, and R. Muraro. 1996. Cell mediated cytotoxicity of human colon carcinoma cells by a monoclonal antibody (R4) recognizing the carcinoembryonic antigen (CEA) and CEA-related molecules. Int. J. Oncol. 8:1127-1135.
3. Ben-Bassat, H., N. Goldblum, S. Mitrani, T. Goldblum, J. M. Yoffey, M. M. Cohen, Z. Bentwich, B. Ramot, E. Klein, and G. Klein. 1977. Establishment in continuous culture of a new type of lymphocyte from a 'Burkitt-Like' malignant lymphoma (line DG75). Int. J. Cancer 19:27-33.
4. Brousset, P., H. Knecht, B. Rubin, E. Drouet, S. Chittal, F. Meggetto, T. A. Saati, E. Bachmann, G. Denoyel, A. Sergeant, and G. Delsol. 1993. Demonstration of Epstein-Barr virus replication in Reed-Sternberg cells of Hodgkin's disease. Blood 82:872-876.
5. Chen, H. F., M. Sauter, P. Haiss, and N. Muller-Lantzsch. 1991. Immunological characterization of the Epstein-Barr virus phosphoprotein PP58 and deoxyribonuclease expressed in the baculovirus expression system. Int. J. Cancer 48:879-888.
6. Countryman, J., and G. Miller. 1985. Activation of the expression of the latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogenous viral DNA. Proc. Natl. Acad. Sci. USA 82:4085-4089.
7. Davis, M. G., and E. S. Huang. 1988. Transfer and expression of plasmids containing human cytomegalovirus immediate-early gene 1 promoter-enhancer sequences in eukaryotic and prokaryotic cells. Biotechnol. Appl. Biochem. 10:6-12.
8. Faggioni, A., C. Zompetta, S. Grimaldi, G. Barile, L. Frati, and J. Lazdins. 1986. Calcium modulation activates Epstein-Barr virus genome in latently infected cells. Science 232:1551-1556.
9. Fries, K. L., T. B. Sculley, J. Webster-Cyriaque, P. Rajadurai, R. H. Sadler, and N. Raab-Traub. 1997. Identitication of a novel protein encoded by the BamHl A region of the Epstein-Barr virus. J. Virol. 71:2765-2771.
10. Ginsburg, M. 1990. Antibodies against the large subunit of the EBV-encoded rihonucleotide reductase in patients with nasopharyngeal carcinoma. Int. J. Cancer 45:1048-1053.
11. Hanto, D. W., G. F. Frizzera, K. J. Gajl-Peczalska, K. Sakamoto, D. T. Purtilo, H. H. Balfour, R. L. Simmons, and J. S. Najarian. 1982 Epstein-Burr virus-induced B-cell lymphoma after renal transplantation. N. Engl. J. Med. 306:91.3-918.
12. Hinuma, Y., M. Konn, J. Yamaguchi, D. J. Wudarski, J. R. Blakeslee, Jr., and J. T. Grace, Jr. 1967. Immunofluorescence and herpes-type particles in the P3HR-1 Burkitt lymphoma cell line. J. Virol. 1:1045-1051.
13. Hudson, G. S., T. J. Gibson, and B. G. Barrell. 1985. The BamHl F region of the B95-8 Epstein-Barr virus genome. Virology 147:99-109.
14. Joab, I., J. C. Nicolas, G. Schwaab, G. de-The, B. Clausse, M. Perricaudet, and Y. Zeng. 1991. Detection of anti-Epstein-Barr virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int. J. Cancer 48:647-649.
15. Katz, B. Z., N. Raab-Trauh, and G. Miller. 1989. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J. Infect. Dis. 160:589-594.
16. Lin, J. C., J. E. Shaw, M. C. Smith, and J. S. Pagano. 1979. Effect of 12-O-tetradecanoyl-phorbol-13-acetate on the replication of the Epstein-Barr virus. I. Characterization of viral DNA. Virology 99:183-187.
17. Littler, E., W. Newman, and J. R. Arrand. 1990. Immunological response of nasopharyngeal carcinoma patients to the Epstein-Barr virus coded thymidine kinase expressed in Escherichia coli. Int. J. Cancer 45:1028-1032.
18. Luka, J., B. Kallinn, and G. Klein. 1979. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94:228-231.
19. Miller, G., and M. Lipman. 1973. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad Sci. USA 70:190-194.
20. Muraro, R., D. Wunderlich, A. Thor, J. Lundy, P. Noguchi, R. Cunningham, and J. Schlom. 1985. Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues. Cancer Res. 45:5769-5780.
21. Pope, J., M. Horne, and W. Scott. 1968. Transformation of fetal human leukocytes in vitro by filtrates of a human leukemic cell line containing herpes-like virus. Int. J. Cancer 3:857-866.
22. Pulvertaft, R. J. V. 1964. Cytology of Burkitt's tumour (African lymphoma). Lancet i:238-240.
23. L34 gene. J. Virol. 65:5757-5764.
24. S3 protein kinase, is a membrane protein which in its unphosphorylated state associates with novel phosphoproteins. J. Virol. 66: 4295-4303.
25. Raab-Traub, N., K. Flynn, G. Pearson, A. Huang, P. Levine, A. Lenier, and J. Pagano. 1987. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int. J. Cancer 39:25-29.
26. Ragoezy, T., L. Heston, and G. Miller. 1998. The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J. Virol. 72:7978-7984.
27. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.). Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
28. L34 gene product is required for viral envelopment. J. Virol. 74:117-129.
29. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
30. Serio, T. R., A. Angeloni, J. L. Kolman, L. Gradoville, R. Sun, D. A. Katz, W. Van Grunsven, J. Middeldorp, and G. Miller. 1996. Two 21-kilodalton components of the Epstein-Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21). J. Virol. 70:8047-8054.
31. Shedd, D., A. Angeloni, J. Niederman, and G. Miller. 1995. Detection of human serum antibodies to the BFRF3 Epstein-Barr virus capsid component by means of a DNA-binding assay. J. Infect. Dis. 172:1367-1370.
32. Takada, K. 1984. Cross-linking of cell surface immunoglobulin induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33:27-32.
33. Takada, K., and Y. Ono. 1989. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63:445-449.
34. Torrisi, M. R., M. Clrone, A. Pavan, C. Zompetta, G. Barile, L. Frati, and A. Faggioni. 1989. Localization of Epstein-Barr virus envelope glycoproteins on the inner nuclear membrane of virus-producing cells. J. Virol. 63:828-832.
35. Uccini, S., F. Monardo, A. Stoppacciaro, A. Gradilone, A. M. Aglianò, A. Faggioni, V. Manzari, L. Vago, G. Costanzi, L. P. Ruco, and C. D. Baroni. 1990. High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients. Int. J. Cancer 46:581-585.
36. van Grunsven, W. M., W. J. Spaan, and J. M. Middeldorp. 1994. Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein. J. Infect. Dis. 170:13-19.
37. van Grunsven, W. M. J., E. C. van Heerde, H. J. W. de Haard, W. J. M. Spaan, and J. M. Middeldorp. 1993. Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins. J. Virol. 67:3908-3916.
38. Yamamoto, M., J. B. Black, J. A. Stewart, C. Lopez, and P. E. Pellett. 1991. Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. J. Clin. Microbiol. 28:1957-1962.
39. Zalani, S., E. Holley-Guthrie, and S. Kenney. 1996. Epstein-Barr viral latency is disrupted by the immediate early BRLF1 protein through a cell-specific mechanism. Proc. Natl. Acad. Sci. USA 93:9194-9199.
40. zur Hausen, H., F. J. O'Neil, U. K. Freese, and E. Hecker. 1978. Persisting oncogenic herpesvirus induced by the tumor promoter TPA. Nature (London) 272:373-375.
41. zur Hausen, H., H. Schulte-Holthausen, G. Klein, W. Henle, G. Henle, P. Clifford, and L. Santesson. 1970. EBV DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature (London) 228:1056-1058.